StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Investment analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA stock opened at $0.01 on Friday. The company’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.02. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.